Search
for
Sort by
Research 631–660 of 1000+
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Efficacy of modern methods for assessing the severity of alopecia areata
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Alopecia Areata
- Alopecia areata; combination therapy with isotretinoin (0.05%) gel and minoxidil (2%) solution
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Ritlecitinib in severe alopecia areata: a profile of its use
- Evaluation of serum zinc level in patients with Alopecia Areata
- Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of the Literature
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Serum 25-Hydroxy Vitamin D Level in Patients with Alopecia Areata and Its Relationship with Severity of the Disease
- Alopecia areata: An update
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- The Role of Micronutrients in Alopecia Areata: A Review
- Alopecia areata update
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Alopecia Areata following Adalimumab
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Organ Specificity in Autoimmune Diseases: Thyroid and Islet Autoimmunity in Alopecia Areata
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
- Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine
- The Pathogenesis of Alopecia Areata in Rodent Models
- Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata